Scientists used gene-editing technology to produce first calf resistant to major viral disease
On May. 9, 2023, the U.S. Department of Agriculture announced that scientists have collaborated to produce the first…
NIH study identified features of Long COVID neurological symptoms
On May 5, 2023, the National Institutes of Health reported that a study had identified features of Long…
World Health Organization reported enterovirus infections in France
On May 5, 2023, France reported an increase in cases of severe neonatal sepsis associated with Enterovirus (Echovirus-11…
World Health Organization ended its declaration of COVID-19 as a global health emergency
On May 5, 2023, the World Health Organization (WHO) ended its declaration of COVID-19 as a global health…
Vertex announced U.S. FDA approval for KALYDECOﾮ to treat eligible Infants withcystic fibrosis ages 1 month and older -First and only CFTR modulator approved for this age group-
On May 3, 2023, Vertex announced the Food and Drug Administration (FDA) ha approved KALYDECOﾮ (ivacaftor) for use…
Elanco announced breakthrough treatment for deadly canine parvovirus
On May 2, 2023, Elanco Animal Health announced that the U.S. Department of Agriculture had provided a conditional…
U.S. Preventive Services Task Force recommended screening for latent tuberculosis infection
On May 2, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
U.S. FDA announced additional steps to advance decentralized clinical trials
On May 2, 2023, the U.S. FDA announced that it was taking additional steps to support the use…
Study raised concerns SARS-CoV-2 evolution outpaces vaccine-generated antibodies
On Apr. 27, 2023, a NIAID-led Phase 2 trial compared two Pfizer bivalent mRNA COVID-19 boosters found that…
Vertex announced U.S. FDA approval for TRIKAFTAﾮ in children with cystic fibrosis ages 2 through 5 with certain mutations
On Apr. 26, 2023, Vertex announced the Food and Drug Administration (FDA) had approved the expanded use of…
U.S. FDA approved treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene
On Apr. 25, 2023, the U.S. FDA approved Qalsody (tofersen) to treat patients with amyotrophic lateral sclerosis (ALS)…
Boehringer Ingelheim inaugurated largest European development centre for biotechnology
On Apr. 24, 2023, Boehringer Ingelheim inaugurated its state-of-the-art Biologicals Development Center in Biberach an der Ri�, Germany….
U.S. FDA approves cell therapy for patients with blood cancers to reduce risk of infection after stem cell transplantation
On Apr. 17, 2023, the U.S. FDA approved Gamida Cell’s Omisirge (omidubicel-onlv), a substantially modified allogeneic (donor) cord…
Additional cases of Marburg virus disease reported in Equatorial Guinea
On Apr. 15, 2023, the World Health Organization (WHO) announced that six additional laboratory-confirmed cases of Marburg virus…
FDA authorizes marketing of MISHAﾙ Knee System for people Suffering from knee osteoarthritis
On Apr. 10, 2023, the U.S. Food and Drug Administration authorized for marketing Moximed’s MISHA Knee System, an…
Highly pathogenic avian influenza confirmed as cause of three California condor mortalities in Arizona
On Apr. 7, 2023, the U.S. National Park Service reported Highly Pathogenic Avian Influenza (HPAI) had been confirmed…
FAO and WHO released report identifying food safety hazards of cell-based food
On Apr. 5, 2023, the Food and Agriculture Organization (FAO), in collaboration with the World Health Organization (WHO),…
Defense Public Health celebrated opening of new $248 million public health laboratory
On Apr. 5, 2023, Aberdeen Proving Ground South, formerly known as Edgewood, celebrated the opening of the Department…
Pfizer RSV vaccine 82% effective vs severe infection in infants, final data showed
On Apr. 5, 2023, Pfizer announced that experimental respiratory syncytial virus (RSV) vaccine was 82% effective in preventing…
NanoViricides announced licensing agreement with Karveer Meditech to commercialize COVID drugs
On Apr. 4, 2023, NanoViricides announced that it had executed a license agreement with Karveer Meditech, Kolhapur, India,…
Extremely rare gene variants point to a potential cause of age-related macular degeneration
On Apr. 3, 2023, a study from the National Eye Institute (NEI) identified rare genetic variants that could…
U.S. Department of Health and Human Services released National Cancer Plan
On Apr. 3, 2023, the U.S. Department of Health and Human Services (HHS) released a National Cancer Plan,…
First case of highly pathogenic Avian influenza confirmed in Klamath County
On Mar. 31, 2023, the Oregon Department of Agriculture and the United States Department of Agriculture’s Animal and…
WHO certified Azerbaijan and Tajikistan as malaria-free
On Mar. 29, 2023, the World Health Organization (WHO) announced that it had certified Azerbaijan and Tajikistan for…
Covid-19 pandemic and the expansion of the mortality gap between the U.S. and its European peers
On Mar. 29, 2023, the mortality gap between the United States and other high-income nations substantially expanded during…
CIRM invested $26 million in research
On Mar. 27, 2023, CIRM Board approved investing nearly $26 million in 17 projects in early-stage discovery research.The…
Thermo Fisher Scientific opened cell therapy facility at University of California, San Francisco
On Mar. 27. 2023, Thermo Fisher Scientific and the University of California, San Francisco, announced they will accelerate…
Guangdong CDC reported an H3N8 infection
On Mar. 26,. 2023, Guangdong Centers for Disease Control in China reported an H3N8 infection that would become…
Climate warming and increasing Vibrio vulnificus infections in North America
On Mar. 23, 2023, a study published in Scientific Reports warned that vibrio vulnificus is an increasingly recognized…
National Science Foundation released reports outlining bold goals for U.S. bioeconomy
On Mar. 22, 2023, the White House Office of Science and Technology Policy released a series of five…